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CASE DEFINITION 
 
Arsenic (Inorganic) 
 
Clinical description 
 
Acute ingestion of toxic amounts of inorganic arsenic typically causes severe gastrointestinal signs and symptoms 
(e.g., vomiting, abdominal pain, and diarrhea). These signs and symptoms might rapidly lead to dehydration and 
shock. Different clinical manifestations might follow, including dysrhythmias (prolonged QT, T-wave changes), 
altered mental status, and multisystem organ failure that might ultimately result in death (1-4).  
 
Laboratory criteria for diagnosis 
 
• Biologic: A case in which elevated urinary arsenic levels (>50 µg/L for a spot or >50 µg total for a 24-hour 
urine) exist, as determined by commercial laboratory tests. Speciation is required in all cases where total 
urine arsenic is elevated to differentiate the amount of organic and inorganic arsenic.  
-OR- 
• Environmental: Detection of arsenic in environmental samples above typical background levels, as 
determined by NIOSH or FDA.  
 
Case classification 
 
• Suspected: A case in which a potentially exposed person is being evaluated by health-care workers or public 
health officials for poisoning by a particular chemical agent, but no specific credible threat exists.  
• Probable: A clinically compatible case in which a high index of suspicion (credible threat or patient history 
regarding location and time) exists for arsenic exposure, or an epidemiologic link exists between this case 
and a laboratory-confirmed case.  
• Confirmed: A clinically compatible case in which laboratory tests have confirmed exposure.  
 
The case can be confirmed if laboratory testing was not performed because either a predominant amount of 
clinical and nonspecific laboratory evidence of a particular chemical was present or a 100% certainty of the 
etiology of the agent is known.  
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This document is based on CDC’s best current information.  It may be updated as new information 
becomes available.  For more information, visit www.bt.cdc.gov/chemical, or call CDC at 
800-CDC-INFO (English and Spanish) or 888-232-6348 (TTY). 
 
